Clinical studies recruiting near Hefei

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · The First Affiliated Hospital of University of Science and T · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · The First Affiliated Hospital of USTC · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Anhui Provincial Cancer Hospital ( Site 2001) · Merck Sharp & Dohme LLC · NCT06136559 Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Phase N/A · The First Affiliated Hospital of University of Science and T · Tianjin Medical University · NCT07685873 Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal
Phase N/A · Anhui provincial hospital · Anhui Provincial Hospital · NCT05833594 A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combin
Phase 1 · The First Affiliated Hospital of University of Science and T · Anhui Provincial Hospital · NCT06232083 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Anhui Provincial Cancer Hospital · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Affiliated Hospital of USTC Anhui Provincial Hospi · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · The First Affiliated Hospital of University of Science and T · Jinling Hospital, China · NCT06118840 Clinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia
NA · The First Affiliated Hospital of Anhui Medical University · The First Affiliated Hospital of Anhui Medical University · NCT07346378 A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Phase 2 · Hanhui Cancer Hospital · Abbisko Therapeutics Co, Ltd · NCT06668103 Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Phase 2 · The First Affiliated Hospital of USTC Anhui Provincial Hospi · Guangdong Association of Clinical Trials · NCT05536505 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · Anhui Provincial Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Anhui Second People's Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
Phase 1 · The Second Affiliated Hospital of Anhui Medical University · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07150962 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Affiliated Hospital of Anhui Medical University · Shanghai Henlius Biotech · NCT07160335 Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
Phase N/A · The First Affiliated Hospital of University of Science and T · Tianjin Medical University · NCT07618936 The Chinese Familial Alzheimer's Network
Phase N/A · The First Affiliated Hospital of Anhui Medical University · Capital Medical University · NCT03657732 Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-2
NA · The First Affiliated Hospital of the University of Science a · The First Affiliated Hospital of University of Science and T · NCT07094763 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · The First Affiliated Hospital of Anhui Medical University · Eli Lilly and Company · NCT07415044 Child-Parent Familial Hypercholesterolemia Screening
Phase N/A · Anhui Provincial Children's Hospital · Children's Hospital of Fudan University · NCT04529967 Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease
EARLY_Phase 1 · The First Affiliated Hospital of the University of Science a · Anhui Provincial Hospital · NCT07208344 Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Phase 2 · The First Affiliated Hospital of University of Science and T · Anhui Provincial Hospital · NCT06693791 An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
Phase N/A · Anhui Provincal Hospital · Anhui Provincial Hospital · NCT06151028 Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
Phase 2 · The First Affiliated Hospital of Anhui Medical University · First Affiliated Hospital of Zhejiang University · NCT07351487 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Anhui Provincial Hospital · Turning Point Therapeutics, Inc. · NCT03093116 The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
Phase N/A · Department of Urology, The First Affiliated Hospital of USTC · Anhui Provincial Hospital · NCT06737588 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · The Second People's Hospital of Hefei · Eli Lilly and Company · NCT07369011 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727

Look up another city

Look up another condition